Genertec Universal Medical Group Company Limited Working Capital to Net Assets Ratio
Genertec Universal Medical Group Company Limited working capital to net assets ratio. Genertec Universal Medical Group Company Limited (5UM) has a Working Capital to Net Assets ratio of 38.5% as of December 2025. Working capital of €9.64 Billion (current assets of €35.90 Billion minus current liabilities of €26.26 Billion) is measured against net assets of €25.04 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Genertec Universal Medical Group Company (5UM) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Genertec Universal Medical Group Company Limited (2016–2025)
Working capital to net assets ratio of Genertec Universal Medical Group Company Limited from 2016 to 2025. This chart shows how Genertec Universal Medical Group Company Limited's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 38.5%, reflecting working capital of €9.64 Billion against net assets of €25.04 Billion EUR. See 5UM defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Genertec Universal Medical Group Company Limited Working Capital to Net Assets Ratio by Year (2016–2025)
Genertec Universal Medical Group Company Limited working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Genertec Universal Medical Group Company Limited from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 5UM total asset value.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 38.5% | €9.64 Billion | €25.04 Billion | €35.90 Billion | €26.26 Billion | ▲ +19.0 pp |
| 2024 | 19.5% | €4.46 Billion | €22.87 Billion | €33.08 Billion | €28.62 Billion | ▲ +16.4 pp |
| 2023 | 3.1% | €621.74 Million | €20.37 Billion | €30.70 Billion | €30.07 Billion | ▼ -215.8 pp |
| 2022 | 218.8% | €43.12 Billion | €19.70 Billion | €69.50 Billion | €26.38 Billion | ▼ -40.9 pp |
| 2021 | 259.8% | €45.78 Billion | €17.62 Billion | €64.51 Billion | €18.73 Billion | ▲ +32.3 pp |
| 2020 | 227.5% | €34.05 Billion | €14.97 Billion | €57.37 Billion | €23.32 Billion | ▼ -35.5 pp |
| 2019 | 263.0% | €35.37 Billion | €13.45 Billion | €54.12 Billion | €18.76 Billion | ▼ -55.6 pp |
| 2018 | 318.6% | €32.68 Billion | €10.26 Billion | €46.50 Billion | €13.83 Billion | ▼ -18.2 pp |
| 2017 | 336.8% | €25.15 Billion | €7.47 Billion | €37.31 Billion | €12.16 Billion | ▲ +8.9 pp |
| 2016 | 327.9% | €21.56 Billion | €6.57 Billion | €28.73 Billion | €7.17 Billion | — |